Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about GILEAD SCIENCES, INC.
08/02GILEAD SCIENCES : UBS Adjusts Gilead Sciences' Price Target to $68 From $64, Mai..
MT
07/30SECTOR UPDATE : Health Care Stocks Scratching Out Small Advance Just Ahead of Fr..
MT
07/30GILEAD SCIENCES : SVB Leerink Adjusts Price Target on Gilead Sciences to $77 Fro..
MT
07/30GLOBAL MARKETS LIVE : Caterpillar, Chevron, Robinhood, Bayer, Gilead Sciences...
07/30GILEAD SCIENCES : BMO Capital Adjusts Gilead Sciences' Price Target to $72 From ..
MT
07/30Today on Wall Street: Without a care in the world
07/30GILEAD SCIENCES : RBC Boosts Price Target on Gilead Sciences to $84 From $81, Ma..
MT
07/30ANALYST RECOMMENDATIONS : Amazon, Barclays, Comcast, Next, Pfizer...
07/29IGM BIOSCIENCES : Names New Chief Medical Officer
MT
07/29GILEAD SCIENCES : View Second Quarter 2021 Prepared Remarks
PU
07/29GILEAD SCIENCES : ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)
PU
07/29GILEAD SCIENCES : View Second Quarter 2021 Summary of Remarks
PU
07/29Gilead Sciences Raises Fiscal Year Product Sales Forecast
DJ
07/29GILEAD SCIENCES : COVID-19 drug helps boost 2nd-quarter results as HIV sales dip
RE
07/29Gilead sciences says no longer pursuing development of inhaled remdesivir for..
RE
07/29Gilead Sciences Swings to 2Q Profit as Revenue Soars 21%
DJ
07/29GILEAD SCIENCES : Posts Q2 Gains Above Estimates, Narrows Annual Guidance Range
MT
07/29GILEAD : Q2 Earnings Snapshot
AQ
07/29GILEAD SCIENCES : View Second Quarter 2021 Earnings Release
PU
07/29GILEAD SCIENCES : View Second Quarter 2021 Earnings Slides
PU
07/29GILEAD SCIENCES : View Second Quarter 2021 Supplementary Info
PU
07/29GILEAD SCIENCES : Earnings Flash (GILD) GILEAD SCIENCES Reports Q2 EPS $1.87, vs..
MT
07/29GILEAD SCIENCES : Earnings Flash (GILD) GILEAD SCIENCES Reports Q2 Revenue $6.22..
MT
07/29GUIDANCE : (GILD) GILEAD SCIENCES Sees Fiscal Year 2021 EPS Range $6.90 - $7.25
MT
07/29GILEAD SCIENCES : Announces Second Quarter 2021 Financial Results
BU
07/29Gilead Sciences, Inc. Revises Earnings Guidance for the Full Year 2021
CI
07/29Gilead Sciences, Inc. Declares Dividend for the Third Quarter of 2021, Payabl..
CI
07/29Gilead Sciences, Inc. Reports Earnings Results for the Second Quarter Ended J..
CI
07/29EARNINGS REACTION HISTORY : Gilead Sciences, 40.0% Follow-Through Indicator, 2.7..
MT
07/27INSIDER TRENDS : Insider at Gilead Sciences Acquires Stock Via Option/Derivative..
MT
07/21GILEAD SCIENCES : Statement on Positive Phase 3 AMBITION Study Findings for the ..
PU
07/20BIONTECH : to Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufa..
AQ
07/20ARCUS BIOSCIENCES : Chief Medical Officer Resigns to Join Gilead's Oncology Team
MT
07/20PRESS RELEASE : Japan becomes first country to approve Ronapreve (casirivimab an..
DJ
07/19ADRs End Lower; Toyota, BioNTech Among Companies Actively Trading
DJ
07/19Health Care Down Amid Defensive Bias -- Health Care Roundup
DJ
07/19GILEAD SCIENCES : BioNTech to Buy Gilead Sciences Unit's Cell Therapy R&D Platfo..
MT
07/19GILEAD SCIENCES : New Phase 3 Data Support the Sustained, Long-Acting Efficacy o..
AQ
07/19GILEAD SCIENCES : Four-Year Biktarvy Data Presented at IAS 2021 Demonstrate High..
AQ
07/19BIONTECH : to Buy Neoantigen TCR Cell Therapy Platform, Facility from Gilead's K..
MT
07/19BioNTech strengthens cancer therapy expertise with U.S. acquisition
RE
07/19PRESS RELEASE : BioNTech to Acquire Kite's Neoantigen TCR Cell Therapy R&D Platf..
DJ
07/19EU evaluates Sobi arthritis drug to treat COVID-19 with pneumonia
RE
07/17GILEAD SCIENCES : New Phase 3 Data Support the Sustained, Long-Acting Efficacy o..
BU
07/17GILEAD SCIENCES : Four-Year Biktarvy« Data Presented at IAS 2021 Demonstrate Hig..
BU
07/17Gilead Sciences, Inc Announces New Results from the Ongoing Phase 2/3 CAPELLA..
CI
07/17Gilead Sciences, Inc Announces Four-Year Biktarvy« Data Presented At Ias 2021..
CI
07/15GILEAD SCIENCES : to Release Second Quarter 2021 Financial Results on Thursday, ..
BU
07/13GILEAD SCIENCES : to Present New Data at IAS 2021 Demonstrating the Company's Co..
AQ
07/12GILEAD SCIENCES : to Present New Data at IAS 2021 Demonstrating the Company's Co..
BU
07/08GILEAD SCIENCES : RBC Capital Adjusts Gilead Sciences PT to $81 From $82 Expecti..
MT
07/07COUNTRYSIDE PROPERTIES : UK's Countryside to focus solely on Partnerships busine..
RE
07/05READY, SET, GO : Crystalize Your Thinking
AQ
07/02GILEAD SCIENCES : Response to Open Letter Regarding Access to AmBisome« (liposom..
PU
06/29GILEAD SCIENCES : Kite Announces Yescarta CAR T-cell Therapy Improved Event-Free..
AQ
06/29EU picks antibody treatments, arthritis drug as preferred COVID-19 therapies
RE
06/29FS DEVELOPMENT II : Blank-Check Firm FS Development II to Merge With Pardes Bios..
MT
06/29BERGENBIO : COVID-19 Drug Cuts Death In Mid-Stage Studies
MT
06/29Pardes Biosciences, Inc. announced that it expects to receive $75 million in ..
CI
06/28GILEAD SCIENCES : Seeks FDA Nod for Lenacapavir for HIV-1 Patients
MT
06/28GILEAD SCIENCES : Submits New Drug Application to U.S. Food and Drug Administrat..
BU
06/28Gilead Sciences, Inc. Submits New Drug Application to U.S. Food and Drug Admi..
CI
06/28GILEAD SCIENCES' : Kite Arm Says Yescarta Improves Event-Free Survival by 60% in..
MT
06/28Gilead Submits NDA for Lenacapavir to U.S. FDA
DJ
06/28GILEAD SCIENCES : Kite Announces Yescarta« CAR T-cell Therapy Improved Event-Fre..
BU
06/27LUPIN : Launches HIV-1 Infection Treatment Drug in US
MT
06/25GILEAD SCIENCES : Treatment with Hepcludex Was Shown to Achieve Significant Resp..
AQ
06/25PRESS RELEASE : Roche's Actemra/RoActemra receives -2-
DJ
06/25PRESS RELEASE : Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Author..
DJ
06/24U.S. approves Roche drug for emergency use against severe COVID-19
RE
06/24GILEAD SCIENCES : Provides Positive Update on Safety, Efficacy of Hepatitis Drug
MT
06/24GILEAD SCIENCES : Treatment With Hepcludex« (Bulevirtide) Was Shown to Achieve S..
BU
06/24Gilead Sciences, Inc. Announces Interim Results from the Phase 2B and Phase 3..
CI
06/24Gilead Sciences Sees Positive Results From Trial for Hepatitis Treatment
DJ
06/23SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma JV Secures CAR T-Cell Therapy Appro..
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
06/15Report 
06/10Report 
05/12Report 
05/12SEC Filing 8K 
05/06SEC Filing 10Q-1 
05/06Report 
Upcoming event on GILEAD SCIENCES, INC.